Fig. 2From: Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?FDG uptake parameters of the ascending aorta for the two clinical response groups. The mean SUVmax and TBR values of the ascending aorta at 6 months after biologic treatment were significantly higher in the group with a DAS28-ESR < 3.2 (indicating remission or low disease activity) than in the group with a DAS28-ESR ≥ 3.2 (indicating moderate or high disease activity). SUVmax, maximum standardized uptake value; TBR, target-to-background ratio; DAS28, Disease Activity Score in 28 joints; RLDA, remission or low disease activity; MHDA, moderate or high disease activityBack to article page